Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

Just a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to step aside by the board following an investigation into suspected illegal activity by Chinese customs. The ...

J&J has struck a deal with Chinese biotech company Genscript, giving it entry to the global market for CAR-T therapies. Despite success in haemato-oncology with drugs such as Imbruvica and Darzalex, ...

From gene therapy to vaccine development, plasmids are vital tools — but only if they’re designed, optimized, and verified with precision. Advances in codon optimization, long-read sequencing, and ...